APIM Therapeutics is developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen).

Biotechnology

Finance

Therapeutics

Venture Capital

APIM Therapeutics

APIM Therapeutics' headquarters in Trondheim, Norway

Kostas Alevizopoulos

Hans Olav Minsås

Marit Otterlei

Erlend Skagseth

Stener Kvinnsland

Farzad Abdi-Dezfuli

Jørgen André Nilsen

Martin Welschof

Birgitte Gangmark Villmo

Gökhan Batur

The Board of Directors at APIM Therapeutics provides strategic oversight and governance, ensuring that the company's activities align with its mission to develop proprietary peptide drugs targeting PCNA. This team is responsible for setting long-term goals, making major corporate decisions, and overseeing the management team’s performance.

Board of Directors

The Leadership Team at APIM Therapeutics, composed of the CEO, Chief Scientific Officer, Chief Medical Officer, and Chief Financial Officer, spearheads strategic decision-making and oversees the company's operations. Their collective responsibilities include guiding scientific research, clinical development, financial planning, and overall corporate strategy to advance the development of proprietary peptide drugs targeting PCNA.

Leadership Team

APIM Therapeutics

Org chart

Board & advisors

Teams

Board of Directors

Leadership Team

Offices

APIM Therapeutics

Org chart

Board & advisors

Teams

Board of Directors

Leadership Team

Offices

Related companies